Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Combined Antiretroviral Therapy”

357 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 357 results

Large-scale testing (Phase 3)Study completedNCT00242840
What this trial is testing

Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 20
Large-scale testing (Phase 3)UnknownNCT00199979
What this trial is testing

Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients

Who this might be right for
Hiv Infection With Antiretroviral Therapy IndicationCD4 Below 350/µL or Below 15%
MEDEX 250
Testing effectiveness (Phase 2)Study completedNCT02588586
What this trial is testing

The Safety and Antiretroviral Activity of 3BNC117

Who this might be right for
HIV-1 Infection
Rockefeller University 17
Large-scale testing (Phase 3)Study completedNCT02489461
What this trial is testing

Efficacy, Safety and Optimal Dose of VM-1500 in Comparison to Efavirenz Added to Standard-of-care Antiretroviral Therapy

Who this might be right for
HIV-1-infection
Viriom 150
Not applicableStudy completedNCT02384395
What this trial is testing

Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection

Who this might be right for
HIVAcute HIV Infection
University of North Carolina, Chapel Hill 40
Testing effectiveness (Phase 2)UnknownNCT01365065
What this trial is testing

Safety and Effect on HIV Transcription of Vorinostat in Patients Receiving Suppressive Combination Anti-retroviral Therapy

Who this might be right for
HIV Positive
Bayside Health 20
Not applicableStudy completedNCT01159743
What this trial is testing

A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir Combined With Tenofovir + Emtricitabine or Lamivudine

Who this might be right for
HIV Infection
AbbVie (prior sponsor, Abbott) 346
Not applicableStudy completedNCT03969550
What this trial is testing

Do CCR5 Antagonists Improve the Overall Survival of Patients With AIDS-related Progressive Multifocal Leucoencephalopathy?

Who this might be right for
AIDSProgressive Multifocal Leucoencephalopathy (PML)
Fondation Ophtalmologique Adolphe de Rothschild 34
Large-scale testing (Phase 3)Study completedNCT00002389
What this trial is testing

The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome 210
Large-scale testing (Phase 3)UnknownNCT02231281
What this trial is testing

Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults

Who this might be right for
Acute HIV Infection
Yongtao Sun, MD, PhD 65
Post-approval studies (Phase 4)Study completedNCT04192487
What this trial is testing

Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea

Who this might be right for
Acquired Immunodeficiency SyndromeHealthy VolunteersHIV/AIDS+2 more
Napo Pharmaceuticals, Inc. 17
Testing effectiveness (Phase 2)Study completedNCT01565850
What this trial is testing

D/C/F/TAF Versus COBI-boosted DRV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment Naive Adults

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infections
Gilead Sciences 153
Large-scale testing (Phase 3)UnknownNCT02902185
What this trial is testing

Chidamide in Combination With ART for Reactivation of the Latent HIV-1 Reservoir

Who this might be right for
Chronic HIV Infections
Tang-Du Hospital 60
Large-scale testing (Phase 3)Study completedNCT01709084
What this trial is testing

A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment

Who this might be right for
Human Immunodeficiency Virus-type 1 Infection
Janssen-Cilag International NV 426
Not applicableEnded earlyNCT05219916
What this trial is testing

Selection of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent HIV Proviruses

Who this might be right for
Human Immunodeficiency Virus I Infection
Hospices Civils de Lyon 17
Large-scale testing (Phase 3)Study completedNCT00561925
What this trial is testing

VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 1,068
Testing effectiveness (Phase 2)Study completedNCT00029341
What this trial is testing

Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the Body

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Not applicableStudy completedNCT00979420
What this trial is testing

Non-interventional Observational Study With Viramune (Nevirapine) and Various Drug Combinations in the Antiretroviral Combination Treatment of HIV-infected Patients Who Have Already Been Treated for Approx. 10 Years With Viramune

Who this might be right for
HIV Infections
Boehringer Ingelheim
Testing effectiveness (Phase 2)Study completedNCT00007202
What this trial is testing

Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Testing effectiveness (Phase 2)Study completedNCT00002227
What this trial is testing

Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Dupont Merck 60
Next Page